Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Signal Transduction and Targeted Therapy|December 24, 2025
Engineered extracellular vesicles reprogram T cells by targeting PD-1 and PHB1 signaling in inflammatory bowel diseaseMi-Kyung Oh, Hyun Sung Park, Dong-Hoon Chae, et al.
Inflammatory Bowel Diseases|July 29, 2022
Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal ResectionJordan E Axelrad, Terry Li, Salam P Bachour, et al.
Nature|October 5, 2022
The γδ IEL effector API5 masks genetic susceptibility to Paneth cell deathYu Matsuzawa-Ishimoto, Xiaomin Yao, Akiko Koide, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 25, 2023
Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn's DiseaseRavi S Shah, Salam Bachour, Abel Joseph, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 7, 2018
Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleedingJordan E Axelrad, Alberto Pinsino, Pauline N Trinh, et al.
Journal of Cardiac Failure|December 4, 2019
Endoscopic Algorithm for Management of Gastrointestinal Bleeding in Patients With Continuous Flow LVADs: A Prospective Validation StudyJordan E Axelrad, Adam S Faye, Alberto Pinsino, et al.
Research Square|August 3, 2021
Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocationMericien Venzon, Lucie Bernard-Raichon, Jon Klein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2023
Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort StudyAriela K Holmer, Jiyu Luo, Kirk B Russ, et al.
Nature Communications|November 2, 2022
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremiaLucie Bernard-Raichon, Mericien Venzon, Jon Klein, et al.
Biorxiv : the Preprint Server for Biology|March 9, 2022
Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocationMericien Venzon, Lucie Bernard-Raichon, Jon Klein, et al.
Pageof 8